Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 11Breast Neoplasms 8Colonic Neoplasms 7Lung Neoplasms 6Brain Neoplasms 4Urinary Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Respiratory Aspiration 2Rectal Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Neoplasm Metastasis 2Melanoma 2Uterine Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Recurrence 1Quality of Recovery 1Postoperative Cognitive Complications 1Pain, Postoperative 1Neurofibromatoses 1Myofibroma 1Lymphoma, Follicular 1Liver Neoplasms 1Liver Functions Tests 1Kidney Neoplasms 1

Interventions

mirdametinib 3Imatinib Mesylate 3Surveys and Questionnaires 2tipifarnib 1talimogene laherparepvec 1pirfenidone 1nilotinib 1emvododstat 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatoses × Sevoflurane × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡